ICD-10 Coding for Mantle Cell Lymphoma(C83.1, C83.10, C83.11)
Explore comprehensive ICD-10 coding and documentation guidelines for mantle cell lymphoma, including remission and site-specific codes.
Complete code families applicable to Mantle Cell Lymphoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C83.1A | Mantle cell lymphoma, in remission | Use when the patient is in remission from mantle cell lymphoma. |
|
| C83.11 | Mantle cell lymphoma, lymph nodes of head, face, and neck | Use when MCL is confirmed in lymph nodes of head, face, or neck. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMantle Cell Lymphoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Mantle Cell Lymphoma.
Ambiguous documentation of lymphoma type
Impact
Clinical: May lead to incorrect treatment, Regulatory: Non-compliance with coding standards, Financial: Potential denial of claims
Mitigation
Ensure clear documentation of immunophenotyping, Use specific lymphoma terminology
Using C83.10 (Unspecified) when the site is documented
Impact
Reimbursement: May lead to incorrect DRG assignment, Compliance: Non-compliance with coding guidelines, Data Quality: Poor data quality and inaccurate health records
Mitigation
Use site-specific codes like C83.11 when the site is known.
Site-specific coding
Impact
Failure to use site-specific codes when documentation is available.
Mitigation
Implement regular audits and coder training on site-specific coding.